Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	February 28, 2023	April 21, 2023	August 25, 2023	Notes Payable	Additional Paid-in Capital	Additional Paid-in Capital February 28, 2023	Additional Paid-in Capital April 21, 2023	Additional Paid-in Capital August 25, 2023	Additional Paid-in Capital Notes Payable	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Class A Common Stock Common Stock	Class A Common Stock Common Stock Notes Payable	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2022													58,682		6,667
Beginning balance at Dec. 31, 2022	$ 200,992					$ 3,724,242					$ 3,505	$ (3,526,755)	$ 0		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)														625,650
Conversion of notes payable and accrued interest into Class A Common Stock					$ 360,668					$ 360,668
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange	(6,811)					(6,811)
Reclassification of earnout shares liability to equity due to authorized share increase		$ 5,014		$ 1,381			$ 5,014		$ 1,381
Reclassification of stock-based awards liability to equity due to authorized share increase		$ 8,978		$ 2,043			$ 8,978		$ 2,043
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares			$ (2,112)					$ (2,112)
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares			$ (2,979)					$ (2,979)
Issuance of common stock (in shares)													368,803
Issuance of common stock	34,492					34,492
Reverse Stock split related round up share issuances (in shares)													2,040
Stock-based compensation	$ 5,101					5,101
Exercise of warrants (in shares)	6,292												5,326
Exercise of warrants	$ 51,276					51,276
Exercise of stock options (in shares)													6
Exercise of stock options	44					44
Issuance of shares for RSU vesting net of tax withholdings (in shares)													352
Issuance of shares for RSU vesting net of tax withholdings	(464)					(464)
Cancellations (in shares)													(26)
Foreign currency translation adjustment	2,357										2,357
Net loss	(431,744)											(431,744)
Ending balance (in shares) at Dec. 31, 2023													1,060,833		6,667
Ending balance at Dec. 31, 2023	228,236					4,180,873					5,862	(3,958,499)	$ 0		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of notes payable and accrued interest into Class A Common Stock (in shares)														62,101,798
Conversion of notes payable and accrued interest into Class A Common Stock					$ 226,341					$ 226,335			$ 6
Reclassification of SPA Warrants from liability to equity	160					160
Issuance of common stock and warrants	10					10
Settlement of Palantir dispute with issuance of Class A Common Stock (in shares)													1,080,294
Settlement of Palantir dispute with issuance of Class A Common Stock	$ 4,800					4,800
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements (in shares)	49,659												49,659
Purchase of Class A Common Stock under Salary Deduction and Stock Purchase Agreements	$ 102					102
Grow Fandor Contribution	250					250
Chongqing related party debt restructuring	661					661
Reverse Stock split related round up share issuances (in shares)													306,779
Stock-based compensation	8,382					8,382
Issuance of shares for RSU vesting net of tax withholdings (in shares)													1,319,764
Issuance of shares for RSU vesting net of tax withholdings	(10)					(10)
Foreign currency translation adjustment	1,882										1,882
Net loss	(355,847)											(355,847)
Ending balance (in shares) at Dec. 31, 2024													65,919,127		6,667
Ending balance at Dec. 31, 2024	$ 114,967					$ 4,421,563					$ 7,744	$ (4,314,346)	$ 6		$ 0